FUNDAMENTALS
EdgeFII/DII
SUNPHARMASUN Pharmaceutical Industries
₹1,884.90-0.79%
Terminal
  • Overview
  • Price
  • Ratios
  • About
  • P&L
  • Balance
  • Cash flow
  • Holders
  • Actions
  • Peers
  • News
SUNPHARMANSE · EquityPharmaceuticals

SUN Pharmaceutical Industries

ISIN
INE044A01036
Instrument key
NSE_EQ|INE044A01036
Open in terminal Fundamentals cached for 6 hours
Last traded price
₹1,884.90-15.10 · -0.79%
Day rangecircuit ₹1,696.50 – ₹2,073.30
1,883.00
1,910.00

as of 21/11/2026, 4:00:37 pm

Open
₹1,898.00
Day high
₹1,910.00
Day low
₹1,883.00
Prev. close
₹1,900.00
Volume
19.16 L
VWAP
₹1,892.13

On this page

Company

  • Overview
  • Price chart
  • Key ratios
  • About

Statements

  • Profit & loss
  • Balance sheet
  • Cash flow

Ownership

  • Shareholding
  • Corporate actions
  • Peers

Market

  • News

02/Price history

Price chart

1 week · 15-minute candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.

1D1W1M6M1Y5YMAX
Change · 1W
+0.06%
1,883.80 → 1,884.90
Period high
₹1,914.80
19/11/2026
Period low
₹1,856.80
16/11/2026
From high
-1.56%
+1.51% from low
Avg volume
66.6K
83.25 L total
Candles
125
56 up / 66 down
20 Nov 2026O 1,892.00H 1,892.00L 1,884.90C 1,884.90Vol 80.4K
SMA 20SMA 50Averages need 50 candles before they begin
Candle data125 rows of open, high, low, close and volumeShowHide
20 Nov 20261,892.001,892.001,884.901,884.90-0.38%7.1080.4K
20 Nov 20261,888.701,892.001,888.101,892.00+0.17%3.901.19 L
20 Nov 20261,890.101,891.901,887.501,888.60-0.08%4.4080.8K
20 Nov 20261,890.601,893.501,889.001,890.40-0.01%4.5051.0K
20 Nov 20261,900.001,900.001,888.801,890.70-0.49%11.201.10 L
20 Nov 20261,906.201,907.901,899.901,899.90-0.33%8.001.40 L
20 Nov 20261,895.901,906.501,894.901,905.70+0.52%11.601.11 L
20 Nov 20261,888.601,896.301,886.701,895.20+0.35%9.6075.5K
20 Nov 20261,888.401,890.201,886.001,888.60+0.01%4.2097.5K
20 Nov 20261,887.101,891.501,885.901,889.00+0.10%5.601.18 L

Historical price and volume data · Showing 1–10 of 125

1 / 13

03/Valuation & returns

Key ratios vs sector

Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.

P/E

Price ÷ earnings per share

41.17
Company
41.17
Sector
-45.02

Worse than sector by 191%

P/B

Price ÷ book value per share

5.07
Company
5.07
Sector
4.21

Worse than sector by 20%

ROA

Net income ÷ total assets

9.61%
Company
9.61%
Sector
1.19%

Better than sector by 708%

ROE

Net income ÷ shareholders' equity

13.79%
Company
13.79%
Sector
-0.4%

Better than sector by 3547%

ROCE

EBIT ÷ capital employed

18.65%
Company
18.65%
Sector
15.44%

Better than sector by 21%

Quick Ratio

Liquid assets ÷ current liabilities

2.31
Company
2.31
Sector
4.8

Worse than sector by 52%

EV/EBITDA

Enterprise value ÷ EBITDA

23.87
Company
23.87
Sector
22.86

Worse than sector by 4%

04/Business

About the company

Sector: Pharmaceuticals

Sun Pharmaceutical Industries Limited is an India-based specialty generic pharmaceutical company with a presence in specialty, generics and consumer healthcare products. The Company's global specialty portfolio spans products in dermatology, ophthalmology, and onco-dermatologym, among others. The Company manufactures and markets a large basket of pharmaceutical formulations across chronic and acute therapies, including generic, branded generics, specialty and complex products, over-the-counter (OTC), antiretrovirals (ARV), Active Pharmaceutical Ingredients (API), and intermediates. Its portfolio spans multiple dosage forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids. Its marketed specialty portfolio includes Ilumya/ Ilumetri, Winlevi, Levulan Kerastick + BLU-U, Absorica LD, Odomzo, Cequa, Bromsite, Xelpros, and others. Its portfolio also includes UNLOXCYTTM, an anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma.

Sector market cap (INR)
₹4,52,299 Cr

reported in crore

Sector market cap (USD)
$50.26B

reported in billion

Market capitalisation is reported at the sector-constituent level, not the standalone company level.

05/Profit & loss

Standalone income statement

Quarterly figures in ₹ crore. Growth marked reported is provided; margins are derived.

YearlyQuarterly
ConsolidatedStandalone
Revenue · Sep 2026
₹6,223 Cr
+5.81% vs Jun 2026
Net profit · Sep 2026
₹871 Cr
-21.87% vs Jun 2026
Operating margin
19.3%
was 25.3%
Revenue CAGR · 4p
2.0%
profit 7.3% · op 3.1%
Filed order
Revenue6,2235,8814,9875,868
Revenue growthreported5.8%17.9%-15.0%—
Operating profit1,2031,4868491,097
Operating profit growthreported-19.1%75.1%-22.6%—
Operating marginderived19.3%25.3%17.0%18.7%
Net profit8711,115609705
Net profit growthreported-21.9%83.2%-13.7%—
Net marginderived14.0%19.0%12.2%12.0%
EPS — basic₹/share, annual——10.90—

Figures in ₹ crore. Margin rows are computed from the reported values.

Full annual line itemsRevenue, other income, expenses, tax, EPSShowHide
Filed order
Revenue20,75522,97720,27520,812
Other Income1,776634553329
Total Revenue22,53123,61220,82921,141
Total Expenses18,19118,63617,16016,463
Profit Before Tax3,7944,9763,4501,741
Tax1,17174859150
Profit After Tax2,6234,2282,8581,691
EPS - Basic10.9017.6011.907.00
EPS - Diluted10.9017.6011.907.00

This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.

06/Balance sheet

Standalone balance sheet

Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.

ConsolidatedStandalone
Total assets · Mar 2026
₹43,060 Cr
-1.87% YoY
Total liabilities
₹20,689 Cr
Net worth
₹22,371 Cr
Liabilities ÷ assets
48.0%
lower means a lighter balance sheet
Filed order
Total assets43,06043,87841,06540,987
Total liabilities20,68919,97817,37017,239
Net worthderived22,37123,90023,69423,748
Liabilities ÷ assetsderived48.0%45.5%42.3%42.1%
Asset growthderived-1.9%6.9%0.2%—

Figures in ₹ crore. Stacked chart height equals total assets.

Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
Filed order
Non-Current Assets26,38125,09826,15224,544
Current Assets16,67918,78114,91316,444
Total Assets43,06043,87841,06540,987
Current Liabilities6,50318,2024,4458,365
Net Current Asset10,17557810,4688,078
Non-Current Liabilities14,1861,77612,9268,874
Equity Capital22,37123,90023,69423,748
Total Equity & Liabilities43,06043,87841,06540,987

Figures in ₹ crore unless the line item is per-share.

07/Cash flow

Standalone cash flow

Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.

ConsolidatedStandalone
Operating · Mar 2026
₹6,501 Cr
+52.89% YoY
Investing
-₹1,381 Cr
Financing
-₹5,230 Cr
Free cash flow
₹5,120 Cr
operating + investing
Filed order
Operating activities6,5014,252-292507
Operating changereported52.9%1554.1%-157.7%—
Investing activities-1,381-258-263-705
Investing changereported-434.9%1.8%62.7%—
Financing activities-5,230-3,836474169
Financing changereported-36.3%-909.4%179.9%—
Net cash flowderived-110158-81-29
Free cash flowoperating + investing5,1203,994-555-198

Figures in ₹ crore.

Full annual line itemsProfit before tax through closing cash balanceShowHide
Filed order
Profit before tax3,7944,9763,4501,741
Income before WC changes5,2586,7605,2196,564
Change in Assets1,308-2,968-1,188-3,600
Change in Liabilities336594-3,981-2,025
Change in WC1,643-2,374-5,169-5,625
Cash flow from Operations6,5014,252-292507
Cash flow from Investing-1,381-258-263-705
Cash flow from Financing-5,230-3,836474169
Total Cash Flow-110158-81-29
Cash (Start of the year)493327410420
Cash (End of the year)418493326410

Figures in ₹ crore unless the line item is per-share.

08/Ownership

Shareholding pattern

Percentage of total shares by holder category across the last 4 reported quarters. Sort any quarter column to rank holders by size.

Promoters
52.68%
-1.80 pts QoQ
FII
14.36%
-0.17 pts QoQ
DII (other)
9.26%
-0.08 pts QoQ
Mutual funds
13.01%
+0.17 pts QoQ
Retail & others
10.70%
+1.89 pts QoQ
Filed order
Promoters52.7%54.5%54.5%54.5%
FII14.4%14.5%15.9%16.1%
DII (other)9.3%9.3%9.2%8.7%
Mutual funds13.0%12.8%12.0%12.1%
Retail & others10.7%8.8%8.5%8.6%
Promoters — QoQ changepts, derived-1.8%0.0%0.0%—
FII — QoQ changepts, derived-0.2%-1.4%-0.2%—
DII (other) — QoQ changepts, derived-0.1%0.2%0.4%—
Mutual funds — QoQ changepts, derived0.2%0.9%-0.1%—
Retail & others — QoQ changepts, derived1.9%0.3%-0.1%—
Totalderived100.0%100.0%100.0%100.0%

Values are percentages of total outstanding shares; QoQ rows are percentage-point moves.

09/Events

Corporate actions

Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.

DividendFinal₹5.00500.0%07 Jul 202607 Jul 202622 May 2026
DividendInterim₹11.001100.0%05 Feb 202605 Feb 202620 Jan 2026

10/Comparison

Peers & competitors

Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.

DIVISLABDivi S Laboratories LtdPharmaceuticals₹11,180.50+0.02%4.05 L₹2,97,325 Cr$33.04B
TORNTPHARMTorrent Pharmaceuticals LPharmaceuticals₹4,689.50+1.70%2.00 L₹1,78,727 Cr$19.86B
LAURUSLABSLaurus Labs LimitedPharmaceuticals₹2,294.60-0.49%8.79 L₹1,24,002 Cr$13.78B
ZYDUSLIFEZydus Lifesciences LtdPharmaceuticals₹1,200.00-0.24%7.80 L₹1,19,207 Cr$13.25B
DRREDDYDR. Reddy S LaboratoriesPharmaceuticals₹1,390.20-0.76%8.31 L₹1,16,145 Cr$12.90B
CIPLACipla LtdPharmaceuticals₹1,415.00-0.25%14.84 L₹1,14,312 Cr$12.70B
MANKINDMankind Pharma LimitedPharmaceuticals₹2,665.00+1.37%4.56 L₹1,09,870 Cr$12.21B
AUROPHARMAAurobindo Pharma LtdPharmaceuticals₹1,799.00-0.37%8.11 L₹1,03,298 Cr$11.48B
LUPINLupin LimitedPharmaceuticals₹2,014.00+0.76%6.31 L₹91,916 Cr$10.21B
GLENMARKGlenmark PharmaceuticalsPharmaceuticals₹2,648.00+1.51%5.40 L₹74,733 Cr$8.30B

Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10

1 / 1

11/Coverage

Company news

Articles published in the last seven days, paginated by the provider.

No news in the last seven days

Company news is available for a rolling one-week window.